| J0897 | Injection, denosumab, 1 mg | 44,340 | $20 | $798.1K |
| J9312 | Injection, rituximab, 10 mg | 7,800 | $60 | $436.8K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 12,750 | $30 | $420.8K |
| J3262 | Injection, tocilizumab, 1 mg | 61,500 | $10 | $307.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,440 | $90 | $207.7K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 17,780 | $10 | $177.8K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,540 | $30 | $144K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 940 | $60 | $55.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 360 | $90 | $34K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 230 | $140 | $32.5K |